Alexion is focused on providing innovative treatments to patients with severe and life-threatening rare diseases for which there are few, if any, effective treatment options. More importantly, we believe that our treatments must reach the patients who are most desperate for solutions.

Alexion is committed to working with private healthcare organisations, policy makers and governments around the world so that patients with rare diseases have access to highly effective, life-transforming therapies. Governments and payors in dozens of countries have recognised the value that innovative medicines can provide to patients with rare diseases. Ongoing partnerships between governments and companies like Alexion can support continuing medical innovation and facilitate access to drug therapies once they are available.